Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Roivant Sciences Ltd. Director's Dealing 2022

Jul 11, 2022

30587_dirs_2022-07-11_6bcf3041-a980-4053-9732-db92fea869cf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2022-06-29

Reporting Person: Epperly Melissa B, (Director)

More from Roivant Sciences Ltd.

Regulatory Filings 2026
May 20
Annual Report 2026
May 20
Regulatory Filings 2026
May 20
Regulatory Filings 2026
Apr 2
Major Shareholding Notification 2026
Mar 27
Director's Dealing 2026
Mar 25
Director's Dealing 2026
Mar 25
Regulatory Filings 2026
Mar 23
Director's Dealing 2026
Mar 19
Director's Dealing 2026
Mar 18
View all filings →